Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Unavailable
    Blood Substitutes
    Unavailable
    Blood Substitutes
    Unavailable
    Blood Substitutes
    Ebook1,745 pages15 hours

    Blood Substitutes

    By Robert M. Winslow

    5/5

    ()

    Currently unavailable

    Currently unavailable

    About this ebook

    Blood substitutes are solutions designed for use in patients who need blood transfusions, but for whom whole blood is not available, or is not safe. This interest has intensified in the wake of the AIDS and hepatitis C epidemics. Blood Substitutes describes the rationale, current approaches, clinical efficacy, and design issues for all blood substitutes now in clinical trials. The many summary diagrams and tables help make the book accessible to readers such as surgeons and blood bankers, who have less technical expertise than the biochemists and hematologists who are designing and testing blood substitutes.

    * Includes chapters necessary to the understanding of blood substitutes, including history, toxicity, physiology, and clinical applications* Presents detailed descriptions of the various products that have been developed and have advanced to clinical trials, and some that are in earlier states of development
    LanguageEnglish
    PublisherAcademic Press
    Release dateOct 5, 2005
    ISBN9780080454146
    Unavailable
    Blood Substitutes
    Author

    Robert M. Winslow

    Professor Winslow received his M.D. degree and postgraduate training in internal medicine and hematology at the Johns Hopkins University and Hospital. He studied hemoglobin biochemistry at the Massachusetts Institute of Technology and Molecular Biology at the National Institutes of Health. His research, for more than 30 years, has been aimed at the intersection of the synthesis, structure and function of hemoglobin, in such areas as sickle cell anemia, high altitude physiology and hemoglobin-based oxygen carriers. Professor Winslow previously headed the Blood Research Division at the Letterman Army Institute of Research, responsible for the US Army's blood substitute program. Between 1991 and 1998, he was a Professor of Medicine, leading a blood substitute program at the University of California at San Diego (UCSD), supported by the National Institutes of Health. Professor Winslow has also served as a consultant to many private companies and has been an advisor for, among others, the Federal Aviation Administration (FAA), Food and Drug Administration (FDA), the Institute of Medicine of the National Academy of Science, the Pan American Health Organization, the National Institutes of Health, the Department of Defense and a number of foreign governments. He has written more than 200 scientific articles on clinical, physiological and biochemical aspects of hemoglobin and oxygen transport.

    Related to Blood Substitutes

    Related ebooks

    Science & Mathematics For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      What Defines a Stem Cell?

      Dec 27, 2018

      For the past three years, researchers at the Hubrecht Institute in the Netherlands have been painstakingly cataloging and mapping all the proliferating cells found in mouse hearts, looking for cardiac stem cells. The elusive cells should theoreticall

      5 min read

    • Article

      Inside Intensive Care

      Jul 9, 2020

      Inside Intensive Care
      3 min read

    • Article

      Repair Therapy

      Jul 8, 2019

      Repair Therapy
      5 min read

    • Article

      With the Nobel Prizes Around the Corner, It’s Crystal Ball Time

      Sep 25, 2017

      The scientists who pioneered immunotherapy and other cancer advances are among the favorites for this year's Nobel Prizes, which will be announced the first week of October.

      4 min read

    • Article

      Speedy Treatment of Sepsis Can Save Lives

      May 22, 2017

      Minutes matter when it comes to treating sepsis, according to a new analysis of nearly 50,000 patients at 149 hospitals. Following the death of Rory Staunton, 12, from undiagnosed sepsis in 2012, New York became the first state to require that hospit

      2 min read

    • Article

      Could CRISPR Kill Cancer Cells?

      Nov 18, 2020

      Could CRISPR Kill Cancer Cells?
      7 min read

    • Article

      This Gene Mutation Causes Some Repeat Miscarriages

      Aug 17, 2018

      A couple’s tragic miscarriages have led to the discovery of a gene mutation underlying hydrops fetalis—a fatal condition to fetuses due to fluid buildup in the space among organs. The proteins at the center of this finding have already been implicate

      3 min read

    • Article

      New Method Flags Athletes Who Dope Blood

      Oct 18, 2018

      Scientists have found a way to help sporting officials detect whether an athlete is guilty of blood doping—infusing their own stored blood to maximize competitive performance. While tests to detect two of the three most common methods of dramatically

      2 min read

    • Article

      Intra-operative Rendez-vous ERCP

      Sep 1, 2022

      Intra-operative Rendez-vous ERCP
      9 min read

    • Article

      There’s An Urgent Need For New Carbon Monoxide Poisoning Treatments. Could Bright Light Be An Antidote?

      Oct 9, 2019

      Experts say there's an urgent need for new treatments for carbon monoxide poisoning. One idea? Combining bright lights and an artificial lung to clean the blood of the toxin.

      3 min read

    • Article

      Bug Vision Findings Could Shed Light On Retina Diseases

      Feb 26, 2024

      A new study shows similarities and differences in human and insect vision formation. The researchers at the University of California, Irvine discovered profound similarities and surprising differences between humans and insects in the production of t

      1 min read

    • Article

      Nanomaterial Found To Reduce Cancer Stem Cells In Rats, Chinese Study Finds

      Sep 28, 2022

      Chinese scientists say they have developed a smart nanomaterial that significantly reduced the number of cancer stem cells in rats in a recent study. Therapies that can selectively eliminate cancer cells mean less damage to a patient's healthy cells.

      2 min read

    • Article

      Through The Keyhole

      Dec 30, 2021

      Through The Keyhole
      3 min read

    Related categories

    Reviews for Blood Substitutes

    5/5

    2 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words